Does anyone know where these special use cases are from ? I assume Australia or maybe NZ as the yanks would be too scared to use anything the FDA hadn't OK'ed as they might get sued out of existence.
Hopefully the word is spreading within the profession & more special use cases will happen, with the same amazing results.
An article on these special use cases in some prestigious medical journal would be handyIt seems to me that would be justified as IMO it is big news.
.
- Forums
- ASX - By Stock
- Ann: Additional Positive Patient Cases - Special Access Scheme
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

Does anyone know where these special use cases are from ? I...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 28921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 0.305 |
4 | 17833 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 28921 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online